Abstract
Human polymorphonuclear neutrophilic leukocytes contain large amounts of neutral proteinases which are released when the granulocytes are exposed to a phagocytic stimulus. In inflammatory diseases local imbalance between these proteinases and available proteinase inhibitors may cause tissue injury as well as degradation of plasma proteins (1,2). Granulocyte elastase (E.C.3.4.21.11) is of special pathological interest because of its high concentration and its broad specificity for a variety of connective tissue components (i.e. elastin, collagen, proteoglycans) and plasma proteins (i.e. IgG, C3, C5, various clotting factors). Though it seems obvious that a quantitative determination of elastase in inflamed tissue and in the circulating blood may give information on disease activity, up to now there have been published only few reports on quantitative assays for the detection and quantitation of elastase in biological fluids (3–6). The main antagonizing agent in plasma for elastase is α1-proteinase inhibitor (7). Upon the interaction of elastase with the inhibitor a complex with a molar ratio of 1 to 1 and a molecular weight of approximately 80,000 Daltons is formed (7,8). We developed a solid-phase enzyme-linked immunoassay for the determination of the complex of elastase with α1-proteinase inhibitor (9,10). By using this assay remarkedly elevated levels of the complex were demonstrated in plasma samples of septicemic patients (11) and in synovial fluids of patients with rheumatoid arthritis (12,13).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
K. Havemann and A. Janoff, eds., “Neutral Proteases of Human Polymorphonuclear Leukocytes”, Urban and Schwarzenberg, Baltimore and Munich (1978).
G. Weissmann, ed., “The Cell Biology of Inflammation”, Elsevier-North Holland, Amsterdam, New York, and Oxford (1980).
R. Egbring, W. Schmidt, G. Fuchs, and K. Havemann, Demonstration of granulocytic proteases in plasma of patients with acute leukemia and septicemia with coagulation defects, Blood 49: 219 1977.
K. Ohlsson and A.-S. Olsson, Immunoreactive granulocyte elastase in human serum, Hoppe-Seyler’s Z. Physiol. Chem. 359: 1531 1978.
U. Kuchich, W.R. Abrams, and H.L. James, Solid-phase immunoassay of dog neutrophil elastase, Anal. Biochem. 109: 403 1980.
E.F. Plow and J. Plescia, Non-plasmin mediated fibrinolysis, in: “Progress in Fibrinolysis V”, J.F. Davidson, I.M. Nilsson, and B. Astedt, eds., Churchill Livingstone, Edinburgh, London, Melbourne, and New York (1981). pp. 70–74.
K. Ohlsson and I. Olsson, Neutral proteases of human granulocytes. III. Interaction between human granulocyte elastase and plasma protease inhibitors, Scand. J.clin. Lab. Invest. 34: 349 1974.
R.J. Baugh and J. Travis, Human leukocyte granule elastase: rapid isolation and characterization, Biochemistry 15: 836 1976.
S. Neumann, N. Hennrich, G. Gunzer, and H. Lang, Enzyme-linked immunoassay for elastase from leukocytes in human plasma, J. Clin. Chem. Clin. Biochem. 19: 232 (1981).
S. Neumann, N. Hennrich, G. Gunzer, and H. Lang, Enzyme-linked immunoassay for complexes of human granulocyte elastase with α1-proteinase inhibitor in plasma, in.: “Progress in Clinical Enzymology II ”, D.M. Goldberg and M. Werner, eds., Masson Publ., New York (1983). in press.
M. Jochum, K.-H. Duswald, E. Hiller, and H. Fritz, Plasma levels of human granulocytic elastase — α1proteinase inhibitor complex (E-α1 PI) in patients with septicemia and acute leukemia, in: “Selected Topics in Clinical Enzymology”, D.M. Goldberg and M. Werner, eds. W.de Gruyter, Berlin-New York (1983); in press.
K. Kleesiek, S. Neumann, and H. Greiling, Determination of the elastase α1-proteinase inhibitor complex, elastase activity and proteinase inhibitors in the synovial fluid, Fresenius Z. Anal. Chem. 311: 434 1982.
K. Kleesiek, D. Brackertz, S. Neumann, and H. Greiling Elastase from granulocytes in chronic joint diseases: Determination of elastase/α1-proteinase inhibitor complex in plasma and synovial fluid. In preparation.
M. Steinbuch and R. Audran, The isolation of IgG from mammalian sera with the aid of caprylic acid, Arch. Biochim. Biophys. 134: 279 1969.
E. Engvall, K. Jonsson, and P. Perlmann, Enzyme-linked immunosorbent assay. II. Quantitative assay of protein antigen, immunoglobulin G, by means of enzyme-labelled antigen and antigen-coated tubes, Biochim. Biophys. Acta 251: 427 1971.
E.F. Plow, Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway, J. Clin. Invest. 69: 564 1982.
L. Olsson, T. Olofsson, K. Ohlsson, and A. Gustavsson, Serum and plasma myeloperoxidase, elastase and lactoferrin content in acute myeloid leukemia, Scand. J. Haematol. 22: 397 1979.
K. Ohlsson, Collagenase and elastase released during peritonitis are complexed by plasma protease inhibitors, Surgery 79: 652 1976.
R.A. Stockley and D. Burnett, Alpha1-antitrypsin and leukocyte elastase in infected and noninfected sputum, Amer. Rev. Resp. Dis. 120: 1081 1979.
H. Menninger, R. Putzier und F. Hartmann, Die Bedeutung von Proteasen für die rheumatische Gelenkdestruktion, Verh. Dtsch. Ges. Rheumatol. 6: 229 1980.
K. Fehr, A. Baici, M. Velvart, M. Knöpfel, M. Rauber, G. Sommermeyer, P. Salgram, G. Cohen und A. Böni, Die chronische Polyarthritis: Rolle der polymorphkernigen Leukozyten bei der Zerstörung von Pannusfreiem Gelenkknorpel, Bull. Schweiz. Akad. Med. Wiss. 35: 317 (1979).
H. Menninger, R. Putzier, W. Mohr, D. Wessinghage, and K. Tillmann, Granulocyte elastase at the site of cartilage erosion by the rheumatoid synovial tissue, Z. Rheumatol. 39: 145 1980.
K. Ohlsson and C.-B. Laurell, The disappearance of enzyme-inhibitor complexes from the circulation of man, Clin. Sci. Mol. Med. 51: 87 1976.
M. Jochum, K.-H. Duswald, S. Neumann, J. Witte, and H, Fritz, Proteinases and their inhibitors in septicemia-Basic concepts and clinical implications — This issue.
W.H. Horl, R.M. Schäfer, K. Scheidhauer, M. Jochum, and A. Heidland, Proteolytic activity in patients with hypercatabolic renal failure. This issue.
A. Heidland, W.H. Hörl, N. Heller, H. Heine, S. Neumann, and E. Heidbreder, Release of granulocyte proteases in patients with acute and chronic renal failure, This issue.
H.P. Schnebli, P. Christen, M. Jochum, R.K. Mallya, and M.B. Pepys, Plasma levels of inhibitor bound leukocytic elastase in rheumatoid arthritis patients, This issue.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Neumann, S., Hennrich, N., Gunzer, G., Lang, H. (1984). Enzyme-Linked Immunoassay for Human Granulocyte Elastase in Complex with α1 -Proteinase Inhibitor. In: Hörl, W.H., Heidland, A. (eds) Proteases. Advances in Experimental Medicine and Biology, vol 167. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9355-3_33
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9355-3_33
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9357-7
Online ISBN: 978-1-4615-9355-3
eBook Packages: Springer Book Archive